The ongoing B-CAST trial [42] evaluates the protein expression of thymidine phosphorylase (TP), dihydropyrimidine dehydrogenase (DPD), EGFR and VEGF in 2128 patients with stage III CRC, but the results are yet to be published. This evidence concerns the gene DPYD and colorectal carcinoma.